1.84
price down icon2.65%   -0.05
after-market After Hours: 1.84
loading
Anebulo Pharmaceuticals Inc stock is traded at $1.84, with a volume of 5,088. It is down -2.65% in the last 24 hours and down -5.64% over the past month. Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
See More
Previous Close:
$1.89
Open:
$1.84
24h Volume:
5,088
Relative Volume:
0.67
Market Cap:
$47.72M
Revenue:
-
Net Income/Loss:
$-10.49M
P/E Ratio:
-3.9149
EPS:
-0.47
Net Cash Flow:
$-9.58M
1W Performance:
-2.90%
1M Performance:
-5.64%
6M Performance:
-37.63%
1Y Performance:
-9.80%
1-Day Range:
Value
$1.83
$1.92
1-Week Range:
Value
$1.83
$1.92
52-Week Range:
Value
$1.72
$3.30

Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile

Name
Name
Anebulo Pharmaceuticals Inc
Name
Phone
737 203 5270
Name
Address
JFL CAPITAL MANAGEMENT, LAKEWAY
Name
Employee
2
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
ANEB's Discussions on Twitter

Anebulo Pharmaceuticals Inc Stock (ANEB) Latest News

pulisher
Oct 29, 2024

Exxaro Resources (OTCMKTS:EXXAY) Share Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World

Oct 29, 2024
pulisher
Oct 29, 2024

Lexeo Therapeutics’ (LXEO) “Buy” Rating Reiterated at Chardan Capital - Defense World

Oct 29, 2024
pulisher
Oct 29, 2024

Short Interest in Janone Inc. (NASDAQ:ALTS) Expands By 10.2% - Defense World

Oct 29, 2024
pulisher
Oct 23, 2024

U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.21% - MSN

Oct 23, 2024
pulisher
Oct 17, 2024

Anebulo Pharmaceuticals Updates Corporate Presentation - TipRanks

Oct 17, 2024
pulisher
Oct 04, 2024

Anebulo To Report Acute Cannabinoid Intoxication Trial Data In June - RTTNews

Oct 04, 2024
pulisher
Oct 01, 2024

Benchmark maintains Speculative Buy on Anebulo stock By Investing.com - Investing.com Canada

Oct 01, 2024
pulisher
Oct 01, 2024

Anebulo Pharmaceuticals (NASDAQ:ANEB) Earns "Speculative Buy" Rating from Benchmark - MarketBeat

Oct 01, 2024
pulisher
Sep 27, 2024

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Up 27.7% in September - Defense World

Sep 27, 2024
pulisher
Sep 25, 2024

Anebulo Pharmaceuticals reports Q4 EPS (5c) vs. (10c) last year - TipRanks

Sep 25, 2024
pulisher
Sep 25, 2024

Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended June 30, 2024 - Marketscreener.com

Sep 25, 2024
pulisher
Sep 25, 2024

Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates - Business Wire

Sep 25, 2024
pulisher
Sep 25, 2024

Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2024 - Marketscreener.com

Sep 25, 2024
pulisher
Sep 24, 2024

Njabulo Blom set to boost Kaizer Chiefs midfield - FarPost

Sep 24, 2024
pulisher
Sep 24, 2024

Kirkland Advises Luminate Capital Partners on its Investment in AbsenceSoft - Legal Desire News Network

Sep 24, 2024
pulisher
Sep 24, 2024

Amway marks “Amway Health Run 2024” to celebrate Nutrilite’s 90th anniversary - Nation Thailand

Sep 24, 2024
pulisher
Sep 23, 2024

Market Movers Monday: KAVL, PRSO, TGL, PNPNF, NVVE Surge on Breaking Developments - openPR

Sep 23, 2024
pulisher
Sep 22, 2024

'Survival instinct kicked in': Survivor of Five Points South mass shooting speaks out - Alabama's News Leader

Sep 22, 2024
pulisher
Sep 22, 2024

Langley double-shooting kills one, injures another - CityNews Vancouver

Sep 22, 2024
pulisher
Sep 22, 2024

Here's Why We're Watching Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation - Yahoo Finance

Sep 22, 2024
pulisher
Sep 22, 2024

One dead, one wounded after 2 men shot in Langley - MSN

Sep 22, 2024
pulisher
Sep 20, 2024

Anebulo Pharmaceuticals Secures NIH Grant for Emergency Cannabis Antidote Development - BP Journal

Sep 20, 2024
pulisher
Sep 20, 2024

Indian Super League: Anwar Ali cleared to play for East Bengal, say reports - Scroll.in

Sep 20, 2024
pulisher
Sep 19, 2024

Anwar Ali receives NOC from AIFFWhen will he make East Bengal debut? - myKhel

Sep 19, 2024
pulisher
Sep 19, 2024

Aligos' fatty liver disease treatment meets main goal in mid-stage study - XM

Sep 19, 2024
pulisher
Sep 18, 2024

AmaZulu coach Pablo Franco defends Veli Mothwa as Kaizer Chiefs game looms - IOL

Sep 18, 2024
pulisher
Sep 18, 2024

Banzai International, Inc. (NASDAQ:BNZI) Sees Large Growth in Short Interest - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Global X Active Canadian Dividend ETF Common (TSE:HAL) Stock Passes Above 200 Day Moving Average of $20.01 - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Applied Therapeutics Surges on Positive FDA Update for Govorestat - BP Journal

Sep 18, 2024
pulisher
Sep 17, 2024

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Sees Significant Growth in Short Interest - MarketBeat

Sep 17, 2024
pulisher
Sep 16, 2024

'Very stupid': Man who helped supply gun later used in Auckland CBD shooting sentenced - New Zealand Herald

Sep 16, 2024
pulisher
Sep 16, 2024

Driver arrested in Muse homicide wants assault charge dropped - Bowling Green Daily News

Sep 16, 2024
pulisher
Sep 15, 2024

Josue is now a KL City legend - New Straits Times

Sep 15, 2024
pulisher
Sep 10, 2024

Scilex Holding (NASDAQ:SCLX) Stock Quotes, Forecast and News Summary - Benzinga

Sep 10, 2024
pulisher
Sep 02, 2024

Short Interest in Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Declines By 5.3% - Defense World

Sep 02, 2024
pulisher
Aug 29, 2024

XORTX Therapeutics Inc ($XRTX): Pioneering New Treatments for Kidney Disease with a Precision-Medicine Approach - BP Journal

Aug 29, 2024
pulisher
Aug 18, 2024

Short Interest in Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Declines By 8.3% - MarketBeat

Aug 18, 2024
pulisher
Aug 18, 2024

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Update - Defense World

Aug 18, 2024
pulisher
Aug 17, 2024

Anebulo Pharmaceuticals Announces New CEO - GuruFocus.com

Aug 17, 2024
pulisher
Aug 08, 2024

Can Actinium Pharmaceuticals (ATNM) bounce back from the Regulatory Hurdles - BP Journal

Aug 08, 2024
pulisher
Aug 06, 2024

Anebulo Pharmaceuticals (NASDAQ:ANEB) Shares Down 4% - Defense World

Aug 06, 2024
pulisher
Aug 02, 2024

Telehealth Innovations (VSEE) on day when Dow loses more than 750 points - BP Journal

Aug 02, 2024
pulisher
Jul 30, 2024

After-Market Stock Rise In Anebulo (ANEB) Indicates Potential Shift In Investor Sentiment - Stocks Telegraph

Jul 30, 2024
pulisher
Jul 24, 2024

Is today’s surge in Dermata Therapeutics (DRMA) justified ? - BP Journal

Jul 24, 2024
pulisher
Jul 23, 2024

Anebulo Pharmaceuticals receives NIDA grant for drug development By Investing.com - Investing.com Canada

Jul 23, 2024
pulisher
Jul 23, 2024

Anebulo Pharmaceuticals receives NIDA grant for drug development - Investing.com

Jul 23, 2024
pulisher
Jul 22, 2024

Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects - Winchester Herald Chronicle

Jul 22, 2024
pulisher
Jul 16, 2024

Adlai Nortye Ltd. (NASDAQ:ANL) Sees Significant Drop in Short Interest - American Banking and Market News

Jul 16, 2024
pulisher
Jul 16, 2024

Tate & Lyle (LON:BD15) Stock Price Passes Above 200 Day Moving Average of $99.00 - American Banking and Market News

Jul 16, 2024
pulisher
Jul 09, 2024

NASDAQ – Stock Price, Charts & News Today - BNN Bloomberg

Jul 09, 2024
pulisher
Jul 01, 2024

Financial Review: Palladyne AI (PDYN) versus Its Rivals - Defense World

Jul 01, 2024

Anebulo Pharmaceuticals Inc Stock (ANEB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Cap:     |  Volume (24h):